Literature DB >> 11950727

Dutch GPs warned against new contraceptive pill.

Tony Sheldon.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 11950727      PMCID: PMC1122825          DOI: 10.1136/bmj.324.7342.869

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Thromboembolism associated with the new contraceptive Yasmin.

Authors:  Kees van Grootheest; Tom Vrieling
Journal:  BMJ       Date:  2003-02-01

2.  An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies.

Authors:  Miguel-Angel Maciá-Martínez; Francisco J de Abajo; Gilly Roberts; Jim Slattery; Bharat Thakrar; Antoni F Z Wisniewski
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

3.  Arterial thrombosis and drospirenone-containing pill (Yasmin). Is the pill to be absolutely avoided by women who smoke?

Authors:  Antonio Girolami; Fabiana Tezza; Emanuele Allemand; Bruno Girolami
Journal:  J Thromb Thrombolysis       Date:  2007-12-23       Impact factor: 2.300

Review 4.  Safety of a new oral contraceptive containing drospirenone.

Authors:  Lothar A J Heinemann; Jürgen Dinger
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.

Authors:  Lianne Parkin; Katrina Sharples; Rohini K Hernandez; Susan S Jick
Journal:  BMJ       Date:  2011-04-21

6.  The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.

Authors:  A van Hylckama Vlieg; F M Helmerhorst; J P Vandenbroucke; C J M Doggen; F R Rosendaal
Journal:  BMJ       Date:  2009-08-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.